Immunohematology Market Size & Forecast Report, 2013 - 2024

Global Immunohematology Market is expected to reach USD 2.3 billion by 2024. Immunohematology, also termed as “Blood Banking”, is a branch of hematology that studies analogous phenomena and RBC antigen-antibody reactions associated with blood transfusions. The Immunohematology industry is estimated to grow at a significant CAGR over the forecast period as the scope and its applications are rising enormously across the globe.

The factors that are playing a major role in the growth of Immunohematology Market are growing awareness among populace regarding transfusion-related diseases and blood compatibility, developing healthcare infrastructure, rising government initiative & reimbursement programs, and increasing concern regarding medical safety across the globe. However, high maintenance cost may restrain overall market growth in the years to come. Immunohematology industry is segmented based on product type, end-user, applications, and region.

Immunohematology reagent and Immunohematology analyzer are the product types that could be explored in Immunohematology in the forecast period. The reagent sector accounted for the substantial market share of immunohematology market and is estimated to lead the overall market in the years to come. This may be because of increasing number of blood banks and rise in use of reagents in the immunohematology tests. Also, Immunohematology analyzer sector is estimated to grow at the fastest pace in the years to come.

The market may be categorized based on end users like diagnostic laboratories, hospitals, blood banks, and others that could be explored in the forecast period. Hospitals sector accounted for the significant market share of Immunohematology and is estimated to continue with its dominance in the years to come. Also, blood banks sector is estimated to grow at the highest CAGR in the years to come. There are several applications that could be explored in Immunohematology such as Hepatitis, Blood-related diseases, HIV, and others.

Globally, North America accounted for the significant market share of Immunohematology and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be developed healthcare infrastructure, growing number of the blood bank and trauma centers, and raised funding by private sectors and governments.

Instead, Europe and the Asia Pacific are also estimated to have a positive influence on the future growth. Europe is the second largest region with significant market share. The aspects that may be ascribed to the growth comprise acceptance and usage of high-quality treatments and diagnostics. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The developing countries like India and China are the major consumers of Immunohematology industry in this region.

The key players of Immunohematology Market are Beckman Coulter, Inc., Bio-Rad Laboratories, Abbott, Immucor, ThermoFisher, Ortho Clinical Diagnostics, Siemens Healthcare GmbH, Grifols, Hologic, Inc., and BD (Becton Dickinson). These players are concentrating on inorganic growth to sustain themselves amongst fierce competition.

Market Segment:

Immunohematology Product Outlook (Market revenue in USD Million, 2013 - 2024)
    • Immunohematology analyzer
    • Immunohematology reagent

Immunohematology End-Use Outlook (Market revenue in USD Million, 2013 - 2024)
    • Hospitals
    • Blood banks
    • Diagnostic laboratories

Immunohematology Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
    • North America
        • U.S.
        • Canada
    • Europe
        • UK
        • Germany
    • Asia Pacific
        • Japan
        • China
    • Latin America
        • Brazil
        • Mexico
    • Middle East and Africa
        • South Africa